Clinical Features	Time to Death		AGE		NEOPLASM.DISEASESTAGE		PATHOLOGY.T.STAGE		PATHOLOGY.N.STAGE		GENDER		RADIATIONS.RADIATION.REGIMENINDICATION		NUMBERPACKYEARSSMOKED		NUMBER.OF.LYMPH.NODES		RACE		ETHNICITY	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	Wilcoxon-test_P	Wilcoxon-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Wilcoxon-test_P	Wilcoxon-test_Q	Wilcoxon-test_P	Wilcoxon-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q
TP53	213 (70%)	93	0.01485	1	0.50892	1	0.0097199	1	0.0056399	1	0.01555	1	0.78076	1	0.12314	1	0.063519	1	0.0077589	1	0.64637	1	0.24276	1
CDKN2A	65 (21%)	241	0.45234	1	0.40941	1	0.27019	1	0.66272	1	0.95198	1	0.63989	1	0.42848	1	0.010743	1	0.78507	1	0.77808	1	0.19742	1
CASP8	27 (9%)	279	0.5091	1	7.6111e-06	0.00225	0.31405	1	0.55861	1	0.083479	1	0.0012748	0.375	0.37202	1	0.21519	1	0.041616	1	0.41893	1	0.35142	1
FAT1	69 (23%)	237	0.71805	1	0.0014219	0.417	0.53322	1	0.45088	1	0.85446	1	0.067685	1	0.75808	1	0.34062	1	0.29506	1	0.19004	1	0.088949	1
MLL2	53 (17%)	253	0.84903	1	0.98773	1	0.3728	1	0.12338	1	0.88507	1	0.86689	1	1	1	0.52008	1	0.91888	1	0.49838	1	1	1
JUB	18 (6%)	288	0.001878	0.548	0.15513	1	0.77708	1	0.45624	1	0.29465	1	1	1	1	1	0.19566	1	0.22145	1	0.090009	1	0.57018	1
NOTCH1	57 (19%)	249	0.83914	1	0.14423	1	0.83497	1	0.75306	1	0.93468	1	0.18751	1	0.40519	1	0.064932	1	0.40315	1	0.93164	1	0.15116	1
NFE2L2	17 (6%)	289	0.57819	1	0.0093885	1	0.69208	1	0.77014	1	1	1	0.26064	1	0.25598	1	0.96513	1	0.67683	1	0.17632	1	0.52402	1
NSD1	33 (11%)	273	0.10284	1	0.086526	1	0.04176	1	0.77809	1	0.00055999	0.165	0.30097	1	0.30141	1	0.091343	1	0.0030102	0.87	0.38318	1	0.051327	1
HRAS	10 (3%)	296	0.21708	1	0.29341	1	0.16045	1	0.24275	1	0.04892	1	1	1	0.46472	1	0.21375	1	0.053365	1	0.68218	1	1	1
ZNF750	13 (4%)	293	0.3778	1	0.82374	1	0.6708	1	0.059499	1	0.74686	1	0.12301	1	0.52517	1	0.67741	1	0.35696	1	0.32481	1	1	1
RASA1	14 (5%)	292	0.98282	1	0.94205	1	0.90895	1	0.52468	1	1	1	0.36448	1	0.53444	1	0.69376	1	0.60761	1	0.53316	1	0.49925	1
HLA-A	9 (3%)	297	0.145	1	0.30703	1	0.42467	1	0.62312	1	0.34014	1	1	1	0.70331	1	0.46259	1	0.70087	1	0.66399	1	1	1
EPHA2	13 (4%)	293	0.96514	1	0.6746	1	0.88766	1	0.95012	1	0.59974	1	0.19917	1	1	1	0.02311	1	0.43872	1	0.11648	1	0.47328	1
RAC1	9 (3%)	297	0.10165	1	0.0021257	0.616	0.37964	1	0.41257	1	0.21784	1	0.067629	1	1	1	0.70086	1	0.16349	1	1	1	1	1
EP300	24 (8%)	282	0.69154	1	0.42684	1	0.59193	1	0.92479	1	0.69303	1	0.48323	1	0.63408	1	0.41284	1	0.94983	1	0.27343	1	0.29626	1
TGFBR2	10 (3%)	296	0.7022	1	0.08129	1	0.87093	1	0.71023	1	0.34003	1	0.4703	1	0.06781	1	0.12034	1	0.48496	1	0.11889	1	1	1
PIK3CA	64 (21%)	242	0.21891	1	0.79007	1	0.43479	1	0.74067	1	0.46734	1	0.11444	1	1	1	0.99561	1	0.46224	1	0.052029	1	1	1
FBXW7	15 (5%)	291	0.49654	1	0.1432	1	0.3602	1	0.63657	1	0.29433	1	0.37184	1	0.55305	1	0.21758	1	0.56782	1	0.15749	1	0.49925	1
RB1	10 (3%)	296	0.39721	1	0.72844	1	0.18099	1	0.23703	1	0.66686	1	0.14455	1	1	1	0.90508	1	0.58213	1	0.23371	1	1	1
CTCF	11 (4%)	295	0.29134	1	0.042229	1	0.63535	1	0.93517	1	0.65541	1	0.1811	1	0.4897	1	0.48908	1	0.18602	1	0.26413	1	1	1
KDM6A	8 (3%)	298	0.21118	1	0.76589	1	0.56517	1	0.45646	1	0.88952	1	0.45323	1	0.686	1	0.98086	1	0.57387	1	0.075189	1	1	1
ELF4	5 (2%)	301	0.92508	1	0.71165	1	0.050509	1	0.20329	1	0.40651	1	1	1	0.33026	1	0.55267	1	0.19191	1	1	1	1	1
RHOA	4 (1%)	302	0.0067545	1	0.76511	1	0.63857	1	0.22254	1	0.40357	1	0.30318	1	0.57641	1	0.47541	1	0.95263	1	1	1	1	1
HLA-B	8 (3%)	298	0.26518	1	0.59704	1	0.29268	1	0.76576	1	0.10896	1	0.22168	1	0.1154	1	0.31078	1	0.092349	1	1	1	1	1
PRSS1	7 (2%)	299	0.88402	1	0.68444	1	0.1878	1	0.91272	1	0.091549	1	0.0020373	0.593	0.19585	1	NA	NA	0.18461	1	0.095329	1	1	1
GUCY2F	8 (3%)	298	0.16112	1	0.96607	1	0.4033	1	0.30438	1	0.66593	1	1	1	0.4404	1	0.70371	1	0.29286	1	0.12061	1	1	1